非小细胞肺癌的预后因素和标记:最近的进展和未来的挑战
Débora Dummer Meira1, Maria Clara de Castro E Caetano1, Matheus Correia Casotti1
1Núcleo de Genética Humana e Molecular, Centro de Ciências Humanas e Naturais, Departamento de Ciências Biológicas, Universidade Federal do Espírito Santo (UFES), Vitória 29075-910, Brazil.
Genes
|October 28, 2023
概括
尽管有新的治疗方法,但非小细胞肺癌 (NSCLC) 的治疗挑战仍然存在. 了解分子遗传学和耐药机制是开发精准医学策略以获得更好的患者结果的关键.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 肺癌,特别是非小细胞肺癌 (NSCLC),由于瘤进展和治疗后复发,仍然是一个重大挑战.
- 目前对NSCLC的治疗策略在预测患者反应和优化组合治疗方面存在局限性.
研究的目的:
- 审查肺癌的分子遗传学,专注于NSCLC.
- 确定对单克隆抗体 (MAbs) 和氨酸激酶抑制剂 (TKIs) 的反应的预测因素.
- 探索NSCLC管理的最佳组合策略和新的治疗方法.
主要方法:
- 通过使用PUBMED,NCBI-PMC和谷歌学术等数据库进行了综合性文献审查.
- 分析的重点是分子标,耐药性机制和NSCLC的新兴疗法.
主要成果:
- 检查了NSCLC的分子遗传学,并根据分子标对抑制剂进行了分类.
- 根据所获得的抗药性模式,划出了治疗替代方案.
- 突出表观遗传疗法和单细胞方法作为新生物标志物的来源.
结论:
- 有效的NSCLC管理需要对预后标志物进行准确的基因型鉴定.
- 准确医学,使得量身定制的药物组合和精确的向,对于未来的治疗进步至关重要.
- 通过新的方法 (如单细胞分析) 识别生物标志物,将完善治疗选择.
更多相关视频
07:42Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
Published on: February 7, 2021
5.0K
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019
10.6K
相关概念视频
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
02:07Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K